On April 28, more than 100+ startups and business leaders convened in Petco Park to engage with the diversity, variety and ambition of the regional life sciences and technology startup scene. UC San Diego featured the largest representation of startups at the event.
Traumatic brain injuries might have faded from the headlines since the NFL reached a $765 million settlement for concussion-related brain injuries, but professional football players aren’t the only ones impacted by these injuries.
Bioengineers and cardiologists from UC San Diego invented a technology that can accurately and noninvasively map atrial and ventricular heart arrhythmias in a matter of minutes. The technology demonstrated 97.3 percent accuracy in a clinical validation study, and recently received FDA clearance.
Using second-long electrical shocks, UC San Diego scientists were able to control the types of cells in a community of bacteria. Being able to direct the ratio of cells holds implications for settings spanning agriculture to health care, where antibiotic resistance is a significant threat.
Elevated levels of an enzyme called PHGDH in the blood of older adults could be an early warning sign of Alzheimer’s disease. Research led by UC San Diego has consistently found high levels of PHGDH expression in brain tissue and blood samples of older adults with different stages of the disease.
UC San Diego scientists use lab-grown human brain tissue to identify neural abnormalities in Pitt-Hopkins Syndrome and show gene therapy tools can rescue neural structure and function.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
